Filing metadata

Accession number
0002044006-26-000002
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Feb 03, 2026
Reporting period
Feb 02, 2026
Description
Insider transaction

Explore SEC Filings Hub